Targeting FcRn for the Generation of Therapeutics

• Cell biological insight into the subcellular trafficking behavior of FcRn and IgG has informed the design of therapeutics
• FcRn inhibitors are now approved for the treatment of antibody-mediated disease
• Different classes of FcRn inhibitors can have distinct behavior at the level of subcellular trafficking

Speakers:

Sally Ward

Professor

University of Southampton